Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

FRA/FUP stock hub

FRA/FUP has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/FUPis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

312.7M

Frankfurt Stock Exchange

Market data

Price

Recent price action with selectable time range.

FRA/FUPFRA/FUP

—

Loading chart…

In the news

Latest news · FRA/FUP

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E24.7

P25 n/aP50 n/aP75 n/a

ROE4.9

P25 n/aP50 n/aP75 n/a

ROIC7.4

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/FUP market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

201

Groups with data

Currency

JPY

Showing 201 of 201 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Japan
Country code	DE
Employees	1,760
Employees Change	102%
Employees Change Percent	6.15
Enterprise value	EUR 459.6M
Exchange	Frankfurt Stock Exchange
Financial currency	JPY
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-05-10
Market cap	EUR 312.7M
Price	EUR 12.1
Price currency	EUR
Rev Per Employee	168,440.67x
Sic	2834
Symbol	fra/FUP
Website	https://www.fujipharma.jp

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.05%
EV Earnings	36.26x
EV/EBIT	12.98x
EV/EBITDA	8.02x
EV/Sales	1.55x
P/B ratio	1.2x
P/E ratio	24.67x
P/S ratio	1.05x
PE Ratio10 Y	13.45x
PE Ratio3 Y	10.08x
PE Ratio5 Y	9.98x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	11.96%
EBITDA Margin	19.36%
Gross margin	40.82%
Gross Profit	EUR 121M
Gross Profit Growth	13.68%
Gross Profit Growth Q	28.54%
Gross Profit Growth3 Y	15.16%
Gross Profit Growth5 Y	8.46%
Net Income	EUR 12.7M
Net Income Growth	-46.95%
Net Income Growth Q	-67.31%
Net Income Growth3 Y	-4.66%
Net Income Growth5 Y	-2.65%
Pretax Margin	5.17%
Profit Margin	4.27%
Profit Per Employee	EUR 7,201
ROA	4.31
Roa5y	3.17
ROCE	10.4
ROE	4.88
Roe5y	8.83
ROIC	7.41
Roic5y	5.17

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	7.21%
Cagr15y	6.76%
Cagr1y	49.64%
Cagr20y	7.18%
Cagr3y	16.72%
Cagr5y	8.72%
Div CAGR10	4.68%
Div CAGR3	1.08%
Div CAGR5	3.28%
EPS Growth	-47.22
EPS Growth Q	-67.48
EPS Growth3 Y	-4.84
EPS Growth5 Y	2.2
Revenue Growth	12.78x
Revenue Growth Q	22.29x
Revenue Growth3 Y	14.9x
Revenue Growth5 Y	9.85x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.58
Assets	EUR 516.5M
Cash	EUR 18.4M
Current Assets	EUR 274.5M
Current Liabilities	EUR 175M
Debt	EUR 165.5M
Debt EBITDA	EUR 2.88
Debt Equity	EUR 0.64
Equity	EUR 260.5M
Interest Coverage	19.31
Liabilities	EUR 256M
Long Term Assets	EUR 242M
Long Term Liabilities	EUR 81.1M
Net Cash	EUR -147.1M
Net Cash By Market Cap	EUR -47.04
Net Debt EBITDA	EUR 2.56
Net Debt Equity	EUR 0.56
Tangible Book Value	EUR 184.7M
Tangible Book Value Per Share	EUR 7.55

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.57
Inventory Turnover	1.49
Net Working Capital	EUR 179.8M
Quick ratio	0.83
Working Capital	EUR 99.9M
Working Capital Turnover	EUR 0.02

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.5%
Dividend Growth	3.37%
Dividend Growth Years	2%
Dividend per share	EUR 0.27
Dividend Years	26
Dividend Yield	2.24%
Ex Div Date	2026-03-30
Last Dividend	EUR 0.12
Payout Frequency	Semi-Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	100.52%
1Y total return	49.6%
200-day SMA	10.22
3Y total return	59.02%
50-day SMA	12.53
50-day SMA vs 200-day SMA	50over200
5Y total return	51.91%
All Time High	30
All Time High Change	-59.67%
All Time High Date	2020-03-18
All Time Low	1.38
All Time Low Change	780%
All Time Low Date	2001-01-03
ATR	0.16
Ch YTD	18.63
High	12.1
High52	13.6
High52 Date	2026-03-27
High52ch	-11.03%
Low	12.1
Low52	7.6
Low52 Date	2025-07-16
Low52ch	59.21%
Ma50ch	-3.45%
Price vs 200-day SMA	18.4%
RSI	45.46
RSI Monthly	65.35
RSI Weekly	58.57
Sharpe ratio	1.4x
Sortino ratio	2.86
Total Return	1.74%
Tr YTD	19.73
Tr15y	166.63%
Tr1m	-9.7%
Tr1w	3.42%
Tr3m	5.28%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 35.5M
Operating Income Growth	23.76
Operating Income Growth Q	122.2
Operating Income Growth3 Y	24.21
Operating Income Growth5 Y	11.51
Operating margin	11.96

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	12,893,063%
Shares Insiders	39.42%
Shares Institutions	14.63%
Shares Qo Q	0.04%
Shares Yo Y	0.5%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	0x
Bv Per Share	10.64
Ch10y	57.74
Ch15y	85.73
Ch1m	-9.7
Ch1w	3.42
Ch1y	45.78
Ch20y	158.5
Ch3m	4.31
Ch3y	45.78
Ch5y	30.81
Ch6m	38.29
Change	0.83%
Change From Open	0
Close	12
Days Gap	0.83
Depreciation Amortization	21,846,524.4
Earnings Date	2026-05-07
EBIT	EUR 35.5M
EBITDA	EUR 57.4M
EPS	EUR 0.52
F Score	5
Fiscal Year End	September
Founded	1,965
Graham Number	10.54674
Graham Upside	-12.84
Income Tax	EUR 2.7M
Is Primary Listing	0
Last Earnings Date	2026-02-05
Last Report Date	2025-12-31
Last Split Date	2018-06-27
Last Split Type	Forward
Lynch Fair Value	EUR 2.45
Lynch Upside	-79.73
Ma150	10.79
Ma150ch	12.17%
Ma20	12.36
Ma20ch	-2.06%
Open	12.1
Payment Date	2026-06-02
Ppne	113,447,668.4
Price Date	2026-05-08
Price EBITDA	EUR 5.45
Ptbv Ratio	1.69
Relative Volume	2,000x
Revenue	296,455,573x
Tax By Revenue	0.9x
Tax Rate	17.39%
Tr20y	300.01%
Tr6m	39.57%
Z Score	2.02

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

FRA/FUP dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.2%

$0.27 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+3.3%

2 consecutive years of growth

Total shareholder yield

+1.7%

Next ex-dividend date: 2026-03-30

Performance

FRA/FUP stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/FUP?

Insider, institutional, and short-interest positioning.

Institutional ownership

+14.6%

Share of float held by funds and institutions

Insider ownership

+39.4%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.5%

Negative means the company is buying back shares.

Technical

FRA/FUP momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

45.5

Neutral momentum band

Price vs 200-day MA

+18.4%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

1.40

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/FUP

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/FUP stock rating?

fra/FUP is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/FUP analysis?

The full report lives at /stocks/fra/FUP/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/FUP?

The latest report frames fra/FUP around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/FUP page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.